Ikuyo Ohguro
Overview
Explore the profile of Ikuyo Ohguro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tanaka S, Watanabe M, Inatomi S, Umeda K, Yoshida K, Ohguro I, et al.
J Ocul Pharmacol Ther
. 2013 Nov;
30(1):12-20.
PMID: 24286181
Purpose: The purpose of the present study was to elucidate the effects of several anti-glaucoma medications on the circadian intraocular pressure (IOP) fluctuations in patients with primary open-angle glaucoma (POAG)....
2.
Yoshida K, Ohguro I, Ohguro H
J Ocul Pharmacol Ther
. 2012 Dec;
29(5):480-7.
PMID: 23259919
Purpose: Our recent study, which involved a randomized, placebo-controlled, double-masked 24-month trial (Ophthalmologica 2012;228:26-35), revealed that oral administration of black currant anthocyanins (BCACs) slowed down the visual field deterioration and...
3.
Ohguro H, Ohguro I, Yagi S
J Ocul Pharmacol Ther
. 2012 Oct;
29(1):61-7.
PMID: 23046438
Purpose: The purpose of the present study was to elucidate the effects of oral administration of black currant anthocyanins (BCACs) on intraocular pressure (IOP) in both healthy subjects and patients...
4.
Ohguro I, Ohguro H
J Ocul Pharmacol Ther
. 2012 Apr;
28(4):392-6.
PMID: 22480163
Purpose: The purpose of the present study is to evaluate the effects of a fixed combination of 0.5% timolol maleate (TM) and 1% dorzolamide hydrochloride (DZ) (FCTD(1%)) on optic nerve...
5.
Ohguro H, Ohguro I, Katai M, Tanaka S
Ophthalmologica
. 2012 Mar;
228(1):26-35.
PMID: 22377796
Aim: To examine the influence of the black currant anthocyanins (BCACs) on the disease progression of open-angle glaucoma (OAG), a randomized, placebo-controlled, double-masked trial was made in 38 patients with...
6.
Abe A, Hiraoka M, Inatomi S, Ohguro I, Ohguro H
Invest Ophthalmol Vis Sci
. 2011 Dec;
53(1):152-6.
PMID: 22159014
Purpose: The present study was conducted to determine lysosomal phospholipase A2 (LPLA2) activity in the aqueous humor (AH) and to identify the possible sources of the LPLA2 found in the...
7.
Ohguro H, Ohguro I, Tsuruta M, Katai M, Tanaka S
Clin Ophthalmol
. 2010 Jul;
4:547-55.
PMID: 20596509
Purpose: To report on the clinically important differences between nasal optic hypoplasia (NOH) and glaucoma with NOH-like temporal visual field defect (VFD). Method: Five NOH (four bilateral and one unilateral)...
8.
Matsuo S, Ohguro H, Ohguro I, Nakazawa M
Ophthalmic Res
. 2009 Nov;
43(3):139-44.
PMID: 19887879
Purpose: Cancer-associated retinopathy (CAR) is an ocular manifestation of a paraneoplastic syndrome whereby immunological reactions toward recoverin, a retina-specific calcium binding protein, and other retinal antigens aberrantly expressed in tumor...
9.
Ohguro I, Ohguro H
Clin Ophthalmol
. 2009 Aug;
2(2):475-8.
PMID: 19668741
This is the first case report of a bilateral superior segmental optic hypoplasia (SSOH) accompanied by a glaucomatous optic neuropathy (GON). A 47-year-old man incidentally diagnosed as having bilateral SSOH,...
10.
Saito Y, Ohguro H, Ohguro I, Sato N, Ishikawa F, Yamazaki H, et al.
Clin Ophthalmol
. 2009 Aug;
2(4):821-8.
PMID: 19668436
To examine rhodopsin (Rho) functions in P23H rat, kinetics of Rho regeneration and dephosphorylation were investigated by spectrophotometric analysis and immunofluorescence labeling method using specific antibodies toward phosphorylated 334Ser or...